Cited by 90Pharmaceutical studies and practicesPharmacy and Medical PracticesPatient Safety and Medication Errors

A systematic review of the use of dosage form manipulation to obtain required doses to inform use of manipulation in paediatric practice

Open access
Richey, Roberta H., Hughes, Clare, Craig, Jean V., Shah, Utpal U., Ford, James L., Barker, Catrin E., Peak, Matthew, Nunn, Anthony J. +1 more·2017·International Journal of Pharmaceutics

Abstract

This study sought to determine whether there is an evidence base for drug manipulation to obtain the required dose, a common feature of paediatric clinical practice. A systematic review of the data sources, PubMed, EMBASE, CINAHL, IPA and the Cochrane database of systematic reviews, was used. Studies that considered the dose accuracy of manipulated medicines of any dosage form, evidence of safety or harm, bioavailability, patient experience, tolerability, contamination and comparison of methods of manipulation were included. Case studies and letters were excluded. Fifty studies were eligible for inclusion, 49 of which involved tablets being cut, split, crushed or dispersed. The remaining one study involved the manipulation of suppositories of one drug. No eligible studies concerning manipulation of oral capsules or liquids, rectal enemas, nebuliser solutions, injections or transdermal patches were identified. Twenty four of the tablet studies considered dose accuracy using weight and/or drug content. In studies that considered weight using adapted pharmacopoeial specifications, the percentage of halved tablets meeting these specifications ranged from 30% to 100%. Eighteen studies investigated bioavailability, pharmacokinetics or clinical outcomes following manipulations which included nine delayed or modified release formulations. In each of these nine studies the entirety of the dosage form was administered. Only one of the 18 studies was identified where drugs were manipulated to obtain a proportion of the dosage form, and that proportion administered. The five studies that considered patient perception found that having to manipulate the tablets did not have a negative impact on adherence. Of the 49 studies only two studies reported investigating children. This review yielded limited evidence to support manipulation of medicines for children. The results cannot be extrapolated between dosage forms, methods of manipulation or between different brands of the same drug.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijpharm.2016.12.032

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is limited literature summarising the evidence available on obtaining the correct dose upon splitting tablets.

    “currently there is limited literature summarising the evidence available on obtaining the correct dose upon splitting tablets.”

    From Does splitting a tablet obtain an accurate dose? A systematic review and meta‐ analysis (2022) · cites this paper as [14]

    The General Discussion (page unavailable) says there is a dearth of evidence about dosage-form manipulation in children, and the dose-accuracy section reviews studies of split-tablet weight and drug content. It does not establish that literature *summarising* tablet-splitting dose accuracy is limited generally; its stated evidence gap is specifically about paediatric practice. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 72

  1. Andersson, AC, Lindemalm S, Eksborg, S. Dividing the tablets for children-good or bad? Pharm Methods, 2016; 7: 23-27
  2. Berg C, Ekedahl A. Dosages involving splitting tablets: common but unnecessary? Journal of Pharmaceutical Health Services Research. 2010; 1: 137-141
  3. Boggie DT, DeLattre ML, Schaefer MG, Morreale AP, Plowman BK. Accuracy of splitting unscored valdecoxib tablets. American Journal of Health-System Pharmacy. 2004; 61: 1482- 1483 "Tablets" In: British Pharmacopoeia (2016) Volume III -Formulated Preparations: General Monographs, Medicines & Healthcare products Regulatory Agency, UK.
  4. Broadhurst EC, Ford JL, Nunn AJ, Rowe PH. Dose uniformity of samples prepared from dispersible aspirin tablets for paediatric use. European Journal of Hospital Pharmacy Science. 2008; 14: 27-31
  5. Carr-Lopez SM, Mallett MS, Morse T. The tablet splitter: barrier to compliance or cost-saving instrument. American Journal of Health-System Pharmacy. 1995; 52: 2707-2708
  6. Choe HM, Stevenson JG, Streetman DS, Heisler M, Sandiford CJ, Piette JD. Impact of patient financial incentives on participation and outcomes in a statin pill-splitting program. American Journal of Managed Care. 2007; 13: 298-304
  7. Chua SS, Chua HM, Omar A. Drug administration errors in paediatric wards: a direct observation approach. European Journal of Pediatrics. 2010; 169: 603-611
  8. Cleary JD, Evans PC, Hikal AH, Chapman SW. Administration of crushed extended-release pentoxifylline tablets: bioavailability and adverse effects. American Journal of Health-System Pharmacy. 1999; 56: 1529-1534
  9. Conroy S, Choonara I, Impiciatore P, Monh A, Arnell H, Rane A, Knoeppel C, Seyberth H, Pandolfini C, Raffealli MP, Rocchi F, Bonati M, Jong G, de Hoog M, van der Anker J. Survey of unlicensed and off label use in paediatric wards in European countries. British Medical Journal. 2000; 320: 79-82
  10. Conroy S, Sweis D, Planner C, Yeung V, Collier J, Haines L, Wong IC. Interventions to reduce dosing errors in children: a systematic review of the literature. Drug Safety. 2007; 30: 1111- 1125.
  11. Cook TJ, Edwards S, Gyemah C, Shah M, Shah I, Fox T. Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10mg tablets. Journal of the American Pharmacists Association. 2004; 44: 583-586
  12. Corbett AH, Hasseinipour MC, Nyirenda J, Kanyama C, Rezk NL, Mkuoani P, Sichali D, Tien H, Kashuba ADM, Mwansambo C, Wiegel R, Kazembe P. Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children. Antiviral Therapy. 2010; 15: 83-90
  13. Costa P, Amaral H, Sousa Lobo JM. Dissolution characteristics of divisible tablets. S.T.P. Pharma Sciences. 2000; 10: 373-377
  14. Duncan MC, Castle SS, Streetman DS. Effect of tablet splitting on serum cholesterol concentrations. The Annals of Pharmacotherapy. 2002; 36: 205-209
  15. Ernest TB, Craig J, Nunn A, Salunke S, Tuleu C, Breitkreutz J, Rainer A, Hempenstall J. Preparation of medicines for children -a hierarchy of classification. International Journal of Pharmaceutics. (2012; 435:124-130 s
  16. Erramouspe J, Jarvi EJ. Effect on dissolution from halving methylphenidate extended-release tablets. The Annals of Pharmacotherapy. 1997; 31: 1123-1126 European Medicines Agency. Assessment report for Tracleer (Bosentan). Procedure No.
  17. Fagerström P-O. Pharmacokinetics of whole and half Theo-Dur tablets. European Journal of Respiratory Diseases. Supplement 109, 1980; 61: 62-66
  18. Fawell NG, Cookson TL, Scranton SS. Relationship between tablet splitting and compliance, drug acquisition cost, and patient acceptance. American Journal of Health-System Pharmacy. 1999; 56: 2542-2545
  19. Ferron GM, Ku S, Abell M, Unruh M, Getsy J, Mayer PR, Paul J. Oral bioavailability of pantoprazole suspended in sodium bicarbonate solution. American Journal of Health-System Pharmacy. 2003; 60: 1324-1329
  20. Fontan JE, Mille F, Brion F. Drug administration to paediatric patients. Archives de Pediatrie. 2004; 11: 1173-1184.
  21. Footitt R. Dose accuracy in paediatric medicine. British Journal of Pharmaceutical Practice. 1983; 5: 16-17,20, 22, 26-27
  22. Gee M, Hasson NK, Hahn T, Ryono R. Effects of a tablet-splitting program in patients taking HMG-CoA reductase inhibitors: analysis of clinical effects, patient satisfaction, compliance, and cost avoidance. Journal of Managed Care Pharmacy. 2002; 8: 453-458
  23. Gerber A, Kohaupt I, Lauterbach KW, Buescher G, Stock S, Lungen M. Quantification and classification of errors associated with hand-repackaging of medications in long-term care facilities in Germany. The American Journal of Geriatric Pharmacotherapy. 2008; 6: 212-219
  24. Green G, Berg C, Polli JE, Barends DM. Pharmacopeial standards for the subdivision characteristics of scored tablets. Pharma Times. 2010; 42: 15-24
  25. Habib WA, Alanizi AS, Abdelhamid MM, Alanizi FK. Accuracy of tablet splitting: Comparison study between hand splitting and tablet cutter. Saudi Pharmaceutical Journal 2014; 22: 454-459
  26. Helmy SA. Tablet Splitting: Is it worthwhile? Analysis of drug content and weight uniformity for half tablets of 16 commonly used medications in the outpatient setting. Journal of Managed Care and Specialty Pharmacy. 2015; 21: 76-86
  27. Hill SW, Varker AS, Karlage K, Myrdal PB. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications. Journal of Managed Care Pharmacy. 2009; 15: 253-261
  28. Horn LW, Kuhn RJ, Kanga JF. Evaluation of the reproducibility of tablet splitting to provide accurate doses for the pediatric population. The Journal of Pediatric Pharmacy Practice. 1999; 4: 38-42
  29. Kayitare E, Vervaet C, Ntawukulilyayoa JT, Seminegaa B, Van Bortel, Remon JP. Development of fixed dose combination tablets containing zidovudine and lamivudine for paediatric applications, International Journal of Pharmaceutics 370 (2009) 41-46
  30. Kim TW, Rognerud CL, Ou C-N. Accuracy in the alteration of acetaminophen suppositories. Anesthesia & Analgesia. 2005; 100:1303-1305
  31. Lucas-Bouwman ME, Roorda RJ, Jansman FG, Brand PL. Crushed prednisolone tablets or oral solution for acute asthma? Archives of Disease in Childhood. 2001; 84: 347-348 Manipulation of Drugs Required in Children (MODRIC); A guide for health professionals. http://www.alderhey.nhs.uk/wp-content/uploads/MODRIC_Guideline_FULL-DOCUMENT.pdf [Accessed 27 November 2016
  32. MacKintosh DA, Baird-Lambert J, Buchanan N. Theo-Dur: No loss of sustained-release effect with chewing or crushing. Australian & New Zealand Journal of Medicine. 1985, 15: 351-352
  33. Mandal TK. Effect of tablet-integrity on the dissolution rate of sustained-release preparations. Journal of Clinical Pharmacy and Therapeutics. 1996; 21: 155-157
  34. McDevitt JT, Gurst AH, Chen Y. Accuracy of tablet splitting. Pharmacotherapy. 1998; 18: 193- 197
  35. McEwen J, Durnin C, McMurdo ME, Moreland TA. Sustained-release verapamil: multiple-dose pharmacokinetic comparison of 120mg and 240mg tablets and the effect of halving a 240mg tablet. Journal of Cardiovascular Pharmacology. 1989; 13 (Suppl 4): S57-S59
  36. Mercovich N, Kyle GJ, Naunton M. Safe to crush? A pilot study into solid dosage form modification in aged care. Australasian Journal on Ageing 2014; 33: 180-184
  37. Mistry P, Batchelor H (2016) Evidence of acceptability of oral paediatric medicines: a review. Journal of Pharmacy & Pharmacology, doi 10.1111/jphp.12610 · DOI
  38. Moreland TA, McMurdo MET, McEwen J. Multiple dose comparison of a whole 240mg verapamil sustained-release tablet with two half tablets. Biopharmaceutics & Drug Disposition. 1989; 10: 311-319
  39. Nahata MC. Pediatric drug formulations: challenges and potential solutions. Annals of Pharmacotherapy. 1999; 33: 127-129.
  40. Nunn AJ. Making medicines that children can take. Archives of Disease in Childhood. 2003; 88: 369-71
  41. Olski TM, Lampus SF, Gherarducci G, Raymond AS. Three years of paediatric regulation in the European Union. European Journal of Clinical Pharmacology. 2011; 67: 245-252
  42. Paradiso LM, Roughead EE, Gilbert AL Cosh D, Nation RL, Barnes L, Cheek J, Ballantyne A. Crushing or altering medications: what"s happening in residential aged-care facilities? Australian Journal on Aging. 2002; 21: 123-127
  43. Parra D, Beckey NP, Raval HS, Schnacky KR, Calabrese V, Coakley RW, Goodhope RC. Effect of splitting simvastatin tablets for control of low-density lipoprotein cholesterol. The American Journal of Cardiology. 2005; 95: 1481-1483
  44. Polli JE, Kim S, Martin BR. Weight uniformity of split tablets required by a Veterans Affairs policy. Journal of Managed Care Pharmacy. 2003; 9: 401-407
  45. Powers JE, Cascella PJ. Comparison of methods used to prepare tablets for nasogastric tube administration. Journal of Pharmacy Technology. 1990; 6: 60-62
  46. Primrose WR, Clee MD, Moody JP, Hockings N. Alteration of pharmacokinetics after halving a slow-release theophylline tablet. Pharmatherapeutica. 1983; 3: 429-432
  47. Rashed SM, Nolly RJ, Robinson L, Thoma L. Weight variability of scored and unscored split psychotropic drug tablets. Hospital Pharmacy. 2003; 38: 930-934
  48. Richey RH, Craig JV., Shah UU, Ford JL, Barker CE, Peak M, Nunn, AJ, Turner M. The manipulation of drugs to obtain the required dose: Systematic review, Journal of Advanced Nursing 2012 68, 2103-2112
  49. Richey RH, Shah UU, Peak M, Craig JV, Ford JL, Barker CE, Nunn AJ, Turner MA, Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence. BMC Pediatrics. 2013a May 21;13:81. doi: 10.1186/1471- 2431-13-81. · DOI
  50. Richey RH, Craig JV, Shah UU, Ford JL, Barker CE, Peak M, Turner M, Nunn AJ. Estimating the requirement for manipulation of medicines to provide accurate doses for children, European Journal of Hospital Pharmacy, 2013b, 20:3-7
  51. Rindone JP. Evaluation of tablet-splitting in patients taking lisinopril for hypertension. Journal of Clinical Outcomes Management. 2000; 7: 22-24
  52. Rosenberg JM, Nathan JP, Plakoglannis F. Weight variability of pharmacist-dispensed split tablets. Journal of the American Pharmaceutical Association. 2002; 42: 200-205
  53. Rosenzweig EB, Ivy DD, Widlitz A, Doran A, Claussen LR, Yung D, Abman SH, Barst RJ. Long-term bosentan treatment in children with pulmonary arterial hypertension -Reply-Journal of the American College of Cardiology. 2006; 47: 1915
  54. Saimbi S, Madden V, Stirling H, Yahyouche A, Batchelor H. Comparison of hydrocortisone 10 mg tablets: tablet hardness optimised for adult use has negative consequences for paediatric use , Arch Dis Child 2016;101:e2 doi:10.1136/archdischild-2016-311535. · DOI
  55. Shah RB, Collier JS, Sayeed VA, Bryant A, Habib MJ, Khan MA. Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium. AAPS PharmSciTech. 2010; 11:1359-1367
  56. Shah VP, Yamamoto LA, Schuirman D, Elkins J, Skelly JP. Analysis of in vitro dissolution of whole vs. half controlled-release theophylline tablets. Pharmaceutical Research. 1987; 4: 416- 419
  57. Simons KJ, Frith EM, Simons FER. Dissolution and bioavailability studies of whole and halved sustained-release theophylline tablets. Journal of Pharmaceutical Sciences. 1982; 71: 505-511
  58. Skwierczynski C, Conroy S. How long does it take to administer oral medicines to children? Paediatric and Perinatal Drug Therapy. 2008; 8: 145-9.
  59. Stimpel M, Vetter H, Küffer B, Groth H, Greminger P, Vetter W. The scored tablet -a source of error in drug dosing? Journal of Hypertension. 1985; 3 (Suppl 1): 97-99
  60. Stockis A, De Bruyn S, Deroubaix X, Jeanbaptiste B, Lebacq E, Nollevaux F, Poli G, Acerbi D. Pharmacokinetic profile of a new controlled-release isosorbide-5-mononitrate 60mg scored tablet (Monoket Multitab®). European Journal of Pharmaceutics and Biopharmaceutics. 2002; 53: 49- 56
  61. Tahaineh LM, Gharaibeh SF. Tablet splitting and weight uniformity of half-tablets of 4 medications in pharmacy practice. Journal of Pharmacy Practice 2012; 25: 471-476
  62. Teng J, Song CK, Williams RL, Polli JE. Lack of medication dose uniformity in commonly split tablets. Journal of the American Pharmaceutical Association. 2002: 42: 195-199
  63. Tuleu C, Grange J, Seurin S. The need for paediatric formulation: oral administration of nifedipine in children, a proof of concept. Journal of Drug Delivery Science and Technology. 2005; 15: 319-324
  64. Turner MA, Catapano M, Hirschfeld S, Giaquinto C; Global Research in Paediatrics. Paediatric drug development: the impact of evolving regulations. Advanced Drug Delivery Review, 2014; 73:2-13.
  65. van Riet-Nales DA, Doeve ME, Nicia AE, Teerenstra S, Notenboom K, Hekster YA, van den Bernt BJF. The accuracy, precision and sustainability of different techniques for tablet subdivision: Breaking by hand and the use of tablet splitters or a kitchen knife. International Journal of Pharmaceutics 2014; 466: 44-51
  66. Van Vooren L, De Spiegeleer B, Thonissen T, Joye P, Van Durme J, Slegers G. Statistical analysis of tablet breakability methods. Journal of Pharmacy and Pharmaceutical Sciences. 2002; 5: 190-198
  67. Verrue C, Mehuys E, Boussery K, Remon JP, Petrovic M. Tablet-splitting: a common yet not so innocent practice. Journal of Advanced Nursing. 2010; 67: 26-32
  68. Vranic E, Uzunovic A. Comparison of some physical parameters of whole and scored Lisinopril and Lisinopril / Hydrochlorthiazide tablets. Bosnian Journal of Basic Medical Sciences. 2008; 8: 391-395
  69. Walker J, Abdulsalam A, Theobald AE, Subrahmanyam R, Verma SK. Multiple-scored tablets. Weight and content uniformity of subdivisions and the distribution of active constituent within and between tablets. Journal of Pharmacy and Pharmacology. 1978; 30: 401-406
  70. Waller DG. Off-label and unlicensed prescribing for children: have we made any progress? British Journal of Clinical Pharmacology. 2007; 64: 1-2
  71. Williams MC, Tsibris JCM, Davis G, Baiano J, O"Brien WF. Dose variation that is associated with approximated one-quarter tablet doses of misoprostol. American Journal of Obstetrics & Gynecology. 2002; 187: 615-619
  72. Zaid AN, Ghosh, AA. Compliance of scored tablet halves produced by Palestinian pharmaceutical companies with the new European Pharmacopoeia requirements. Archives of Pharmacal Research 2011, 34, 1183-1189

Cited by

Sorted by citations

Authors
Richey, R. H., Hughes, C., Craig, J. V., Shah, U. U., Ford, J. L., Barker, C. E., Peak, M., Nunn, A. J., & Turner, M. A.
Affiliations
  • Walton Centre (GB)
  • Liverpool John Moores University (GB)
  • University of East Anglia (GB)
  • Alder Hey Children's NHS Foundation Trust (GB)
  • University of Liverpool (GB)
Corresponding author
Ford, James L.
Venue
International Journal of Pharmaceutics
Publisher
Elsevier BV
Published
2017-02
Volume
518
Issue
1-2
Pages
155-166
ISSN
0378-5173 (ISSN-L)
OpenAlex
W2563046258
Cited by
90
References
0
Citations by year
2026: 7 · 2025: 11 · 2024: 7 · 2023: 12 · 2022: 11 · 2021: 10 · 2020: 10 · 2019: 11 · 2018: 9 · 2017: 2
FWCI
1.13
Type
journal article
Language
en
Open access
Locations
  • International Journal of Pharmaceutics (publishedVersion)
  • PubMed (publishedVersion)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
Funders
  • National Institute for Health Research (PB-PG-0807-13260)
  • Research for Patient Benefit
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
  • Health Sciences › Health Professions › Emergency Medical Services › Patient Safety and Medication Errors
Keywords
pediatric dosing, tablet splitting, tablet crushing, dose accuracy, bioavailability, pharmacokinetics, modified-release formulation, patient adherence, drug safety, pediatric pharmacy
MeSH terms
Dosage Forms, Drug Therapy, Pharmaceutical Preparations, Humans, Pediatrics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review